[ Hound Labs raises $8.1M in Series B ]
Hound Labs has raised $8.1 million in Series B funding.
Founded in 2014, Hound Labs designs, develops and manufactures breathalyzers that allow users to measure recent marijuana and alcohol levels in their breath.
The company intends to use the funds to continue to start of clinical trials to verify the efficacy of its field-tested device. The first clinical trials began earlier this month at San Francisco General Hospital.
|Founder / CEO||Mike Lynn|